申请人:Estee Lauder, Inc.
公开号:US05683705A1
公开(公告)日:1997-11-04
Novel sulfhydryl group-containing amides and disulfide group-containing bis-amides useful for treating or preventing an abnormal biological condition or a disease, and/or improving the texture or appearance of the skin, as well as compositions containing amides and bis-amides and methods for their use are described. Such types of abnormal biological conditions or diseases include skin atrophy, i.e., the thinning and/or general degradation of the dermis often characterized by a decrease in collagen and/or elastin as well as decreased number, size and doubling potential of fibroblast cells, and other maladies including, but are not limited to dry skin, severe dry skin, dandruff, acne, keratoses, psoriasis, eczema, skin flakiness, pruritus, age spots, lentigines, melasmas, wrinkles, warts, blemished skin, hyperpigmented skin, hyperkeratotic skin, inflammatory dermatoses, age-related skin changes and skin in need of cleansers.
本发明描述了一种新型含巯基基团的酰胺和含二硫键基团的双酰胺,用于治疗或预防异常生物状况或疾病,改善皮肤质地或外观,以及含有酰胺和双酰胺的组合物和使用它们的方法。此类异常生物状况或疾病包括皮肤萎缩,即表皮稀疏和/或普遍退化,通常表现为胶原蛋白和/或弹性蛋白减少,以及成纤维细胞数量、大小和倍增潜力减少,以及其他疾病,包括但不限于干燥皮肤、严重干燥皮肤、头皮屑、痤疮、角化病、银屑病、湿疹、皮肤脱屑、瘙痒、老年斑、黑色素斑、黄褐斑、皱纹、疣、皮肤瑕疵、色素沉着皮肤、角质过度增生皮肤、炎症性皮肤病、与年龄相关的皮肤变化和需要清洁剂的皮肤。